Rondo Therapeutics Funding: $67M Raised, Series A (2022)
Rondo Therapeutics is based in San Francisco. It has raised $67M in total funding. Latest round: Series A.
Rondo Therapeutics funding overview
Rondo Therapeutics is based in San Francisco. Rondo Therapeutics has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Rondo Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Red Tree Venture Capital, Canaan Partners, Johnson & Johnson Innovation – JJDC, Inc., Novo Holdings A/S, SV Health Investors. 5 distinct backers are named across the disclosed rounds.
Rondo Therapeutics at a glance
Total raised
$67M
Latest round
Series A
Latest round date
March 2022
Headquarters
San Francisco
Notable investors
Red Tree Venture Capital, Canaan Partners, Johnson & Johnson Innovation – JJDC, Inc., Novo Holdings A/S, SV Health Investors
Frequently asked about Rondo Therapeutics funding
How much has Rondo Therapeutics raised?
Rondo Therapeutics has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Rondo Therapeutics?
Red Tree Venture Capital, Canaan Partners, Johnson & Johnson Innovation – JJDC, Inc., Novo Holdings A/S, SV Health Investors are named among the investors backing Rondo Therapeutics.
What was the latest Rondo Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Rondo Therapeutics based?
Rondo Therapeutics is based in San Francisco.
When did Rondo Therapeutics last raise?
The last disclosed Rondo Therapeutics round closed in March 2022 at Series A.
Rondo Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.
